Sharp to become top shareholder in Pioneer in capital tie-up

Sharp to become top shareholder in Pioneer in capital tie-up

TOKYO, Japan - Sharp Corp. President Mikio Katayama (front) and Pioneer Corp. President Tamihiko Sudo hold a joint news conference at a hotel in Tokyo on Sept. 20 to announce the two companies' business and capital tie-up. (Kyodo)

  • Product Code
  • ILEA000037340
  • Registered date
  • 2007/9/20 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1710 × 1228 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 408.65(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    UnitedHealthcare Corporate Headquarters

    UnitedHealthcare Corporate Headquarters

    A security guard walks towards the front of the UnitedHealthcare corporate headquarters in Minnetonka, on December 5, 2024. Increased security measures are put in place at the company's headquarters after UnitedHealthcare Insurance CEO Brian Thompson is murdered in a shooting in front of the Midtown Manhattan Hilton hotel in New York City, where he is attending an annual investors conference for UnitedHealthcare. (Photo by Steven Garcia/NurPhoto)
      UnitedHealthcare Corporate Headquarters

      UnitedHealthcare Corporate Headquarters

      A security guard walks towards the front of the UnitedHealthcare corporate headquarters in Minnetonka, on December 5, 2024. Increased security measures are put in place at the company's headquarters after UnitedHealthcare Insurance CEO Brian Thompson is murdered in a shooting in front of the Midtown Manhattan Hilton hotel in New York City, where he is attending an annual investors conference for UnitedHealthcare. (Photo by Steven Garcia/NurPhoto)
        UnitedHealthcare Corporate Headquarters

        UnitedHealthcare Corporate Headquarters

        The UnitedHealthcare logo is seen on the corporate headquarters building in Minnetonka, Minnesota, on December 5, 2024, the day after UnitedHealthcare Insurance CEO Brian Thompson is murdered in a shooting in front of the Midtown Manhattan Hilton hotel in New York City, where he is attending an annual investors conference for UnitedHealthcare. (Photo by Steven Garcia/NurPhoto)
          UnitedHealthcare Corporate Headquarters

          UnitedHealthcare Corporate Headquarters

          The UnitedHealthcare logo is seen on the corporate headquarters building in Minnetonka, Minnesota, on December 5, 2024, the day after UnitedHealthcare Insurance CEO Brian Thompson is murdered in a shooting in front of the Midtown Manhattan Hilton hotel in New York City, where he is attending an annual investors conference for UnitedHealthcare. (Photo by Steven Garcia/NurPhoto)
            UnitedHealthcare Corporate Headquarters

            UnitedHealthcare Corporate Headquarters

            The front of the UnitedHealthcare corporate headquarters in Minnetonka, Minnesota, on December 5, 2024, shows flags flying at half-mast for UnitedHealthcare Insurance CEO Brian Thompson, who is murdered in a shooting in front of the Midtown Manhattan Hilton hotel in New York City, where he is attending an annual investors conference for UnitedHealthcare. (Photo by Steven Garcia/NurPhoto)
              UnitedHealthcare Corporate Headquarters

              UnitedHealthcare Corporate Headquarters

              The front of the UnitedHealthcare corporate headquarters in Minnetonka, Minnesota, on December 5, 2024, shows flags flying at half-mast for UnitedHealthcare Insurance CEO Brian Thompson, who is murdered in a shooting in front of the Midtown Manhattan Hilton hotel in New York City, where he is attending an annual investors conference for UnitedHealthcare. (Photo by Steven Garcia/NurPhoto)
                Economy Warsaw

                Economy Warsaw

                A view of Novotel hotel in Warsaw, Poland on November 18, 2024. (Photo by Jakub Porzycki/NurPhoto)
                  Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                  Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                  BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                    Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                    Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                    BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                      Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                      Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                      BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)